Molecular Testing in Metastatic Gastric/GEJ Cancer

3 Vues
administrator
administrator
06/30/23

David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.

  • Catégorie

Montre plus

Aucun commentaire trouvé

Commentaires de Facebook

Suivant